{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,26]],"date-time":"2026-07-26T14:04:32Z","timestamp":1785074672709,"version":"3.55.0"},"reference-count":128,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,6,8]],"date-time":"2026-06-08T00:00:00Z","timestamp":1780876800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100010618","name":"Guangzhou University of Chinese Medicine","doi-asserted-by":"publisher","award":["GZYZS2024XKG03"],"award-info":[{"award-number":["GZYZS2024XKG03"]}],"id":[{"id":"10.13039\/501100010618","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002367","name":"Chinese Academy of Sciences","doi-asserted-by":"publisher","award":["2025ZD0547100"],"award-info":[{"award-number":["2025ZD0547100"]}],"id":[{"id":"10.13039\/501100002367","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002367","name":"Chinese Academy of Sciences","doi-asserted-by":"publisher","award":["XDB1060000"],"award-info":[{"award-number":["XDB1060000"]}],"id":[{"id":"10.13039\/501100002367","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100015361","name":"University of the Chinese Academy of Sciences","doi-asserted-by":"publisher","award":["2025UPD008"],"award-info":[{"award-number":["2025UPD008"]}],"id":[{"id":"10.13039\/501100015361","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100017291","name":"Zhongshan Science and Technology Bureau","doi-asserted-by":"publisher","award":["2023B2031"],"award-info":[{"award-number":["2023B2031"]}],"id":[{"id":"10.13039\/501100017291","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100010871","name":"Recruitment Program of Global Experts","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100010871","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007162","name":"Guangdong Provincial Department of Science and Technology","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100007162","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100013152","name":"Shanghai Institute of Materia Medica, Chinese Academy of Sciences","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100013152","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Pharmacological Research"],"published-print":{"date-parts":[[2026,8]]},"DOI":"10.1016\/j.phrs.2026.108287","type":"journal-article","created":{"date-parts":[[2026,6,9]],"date-time":"2026-06-09T15:48:32Z","timestamp":1781020112000},"page":"108287","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Receptor-interacting protein kinases (RIPK1\u2013RIPK4) in cardiac pathophysiology: Mechanistic signaling, disease contexts, and emerging pharmacological targets"],"prefix":"10.1016","volume":"230","author":[{"ORCID":"https:\/\/orcid.org\/0009-0002-5961-3541","authenticated-orcid":false,"given":"Basma Refai Ali","family":"Mohamed","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mengdie","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiafeng","family":"Xie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abdallah Iddy","family":"Chaurembo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinyu","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8754-2272","authenticated-orcid":false,"given":"Na","family":"Xing","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Han-Bin","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"10","key":"10.1016\/j.phrs.2026.108287_bib1","doi-asserted-by":"crossref","DOI":"10.1007\/s00018-023-04917-2","article-title":"Functions of the RIP kinase family members in the skin","volume":"80","author":"Urwyler-R\u00f6sselet","year":"2023","journal-title":"Cell. Mol. Life Sci."},{"key":"10.1016\/j.phrs.2026.108287_bib2","doi-asserted-by":"crossref","DOI":"10.1172\/JCI152297","article-title":"TAB2 deficiency induces dilated cardiomyopathy by promoting RIPK1-dependent apoptosis and necroptosis","volume":"132","author":"Yin","year":"2022","journal-title":"J. Clin. Investig."},{"key":"10.1016\/j.phrs.2026.108287_bib3","first-page":"480","article-title":"RIP3 orchestrates oxidative stress and pyroptosis in doxorubicin-induced cardiotoxicity through regulation of AKT\/Nrf2 signaling cascade","author":"Wang","year":"2025","journal-title":"Mol. Cell. Biochem."},{"key":"10.1016\/j.phrs.2026.108287_bib4","article-title":"RIPK4 promotes oxidative stress and ferroptotic death through the downregulation of ACSM1","volume":"121","author":"Zhang","year":"2024","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.phrs.2026.108287_bib5","doi-asserted-by":"crossref","DOI":"10.31083\/RCM38407","article-title":"Programmed cell death in heart failure: mechanisms, impacts, and therapeutic prospects","volume":"26","author":"Wu","year":"2025","journal-title":"Rev. Cardiovasc. Med."},{"key":"10.1016\/j.phrs.2026.108287_bib6","article-title":"Si-Miao-Yong-An decoction suppresses necroptosis by regulating the p53 pathway in myocardial ischemia\/reperfusion injury","volume":"15","author":"Li","year":"2025","journal-title":"Sci. Rep."},{"key":"10.1016\/j.phrs.2026.108287_bib7","doi-asserted-by":"crossref","DOI":"10.1186\/s13020-021-00458-7","article-title":"Tanshinone I exerts cardiovascular protective effects in vivo and in vitro through inhibiting necroptosis via Akt\/Nrf2 signaling pathway","volume":"16","author":"Zhuo","year":"2021","journal-title":"Chin. Med."},{"key":"10.1016\/j.phrs.2026.108287_bib8","article-title":"The role of RIPK3-regulated cell death pathways and necroptosis in the pathogenesis of cardiac ischaemia-reperfusion injury","volume":"231","author":"Ying","year":"2021","journal-title":"Acta Physiol. (Oxf. Engl. )"},{"key":"10.1016\/j.phrs.2026.108287_bib9","doi-asserted-by":"crossref","DOI":"10.1093\/cvr\/cvac066.055","article-title":"A novel receptor-interacting protein-1 (RIP1) inhibitor (547) protects human cardiac cells from ischemia\/reperfusion-triggered necroptotic cell death","volume":"118","author":"Peters","year":"2022","journal-title":"Cardiovasc. Res."},{"key":"10.1016\/j.phrs.2026.108287_bib10","doi-asserted-by":"crossref","DOI":"10.3390\/biomedicines10010127","article-title":"Interplay of Oxidative Stress and Necrosis-like Cell Death in Cardiac Ischemia\/Reperfusion Injury: A Focus on Necroptosis","volume":"10","author":"Adameova","year":"2022","journal-title":"Biomedicines"},{"key":"10.1016\/j.phrs.2026.108287_bib11","doi-asserted-by":"crossref","DOI":"10.3389\/fcvm.2021.696362","article-title":"RIP1\/RIP3\/MLKL mediates myocardial function through necroptosis in experimental autoimmune myocarditis","volume":"8","author":"Wu","year":"2021","journal-title":"Front. Cardiovasc. Med."},{"key":"10.1016\/j.phrs.2026.108287_bib12","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2021.762334","article-title":"Receptor interacting protein Kinases 1\/3: the potential therapeutic target for cardiovascular inflammatory diseases","volume":"12","author":"Leng","year":"2021","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.phrs.2026.108287_bib13","doi-asserted-by":"crossref","DOI":"10.1038\/s41569-023-00946-3","article-title":"The role of the NLRP3 inflammasome and pyroptosis in cardiovascular diseases","volume":"21","author":"Toldo","year":"2024","journal-title":"Nat. Rev. Cardiol."},{"key":"10.1016\/j.phrs.2026.108287_bib14","doi-asserted-by":"crossref","DOI":"10.1038\/s41420-021-00579-w","article-title":"Ferroptosis: a cell death connecting oxidative stress, inflammation and cardiovascular diseases","volume":"7","author":"Yu","year":"2021","journal-title":"Cell. Death Discov."},{"key":"10.1016\/j.phrs.2026.108287_bib15","doi-asserted-by":"crossref","DOI":"10.1038\/s41419-022-04587-1","article-title":"RIPK1-RIPK3 mediates myocardial fibrosis in type 2 diabetes mellitus by impairing autophagic flux of cardiac fibroblasts","volume":"13","author":"Qiao","year":"2022","journal-title":"Cell. death & Dis."},{"key":"10.1016\/j.phrs.2026.108287_bib16","article-title":"Ca2+\/calmodulin-dependent protein kinase ii regulation by inhibitor of RIPK3 protects against cardiac hypertrophy","volume":"2022","author":"Zhang","year":"2022","journal-title":"Oxid. Med. Cell. Longev."},{"key":"10.1016\/j.phrs.2026.108287_bib17","article-title":"Lipoprotein-associated phospholipase A2 is linked with poor cardio-metabolic profile in patients with ischemic stroke: a study of effects of statins","volume":"9","author":"Alkuraishy","year":"2018","journal-title":"J. Neurosci. Rural. Pract."},{"key":"10.1016\/j.phrs.2026.108287_bib18","article-title":"RIPK protein kinase family: atypical lives of typical kinases","volume":"109","author":"Cuny","year":"2020","journal-title":"Semin. Cell. & Dev. Biol."},{"key":"10.1016\/j.phrs.2026.108287_bib19","doi-asserted-by":"crossref","DOI":"10.1016\/j.yjmcc.2018.01.018","article-title":"Programmed necrosis in heart disease: molecular mechanisms and clinical implications","volume":"116","author":"Zhu","year":"2018","journal-title":"J. Mol. Cell. Cardiol."},{"key":"10.1016\/j.phrs.2026.108287_bib20","doi-asserted-by":"crossref","DOI":"10.3892\/ijmm.2023.5301","article-title":"Role of RIPK3-CaMKII-mPTP signaling pathway-mediated necroptosis in cardiovascular diseases (Review)","volume":"52","author":"Chen","year":"2023","journal-title":"Int. J. Mol. Med."},{"key":"10.1016\/j.phrs.2026.108287_bib21","doi-asserted-by":"crossref","DOI":"10.1155\/2019\/6173685","article-title":"ZYZ-803 mitigates endoplasmic reticulum stress-related necroptosis after acute myocardial infarction through downregulating the RIP3-CaMKII signaling pathway","volume":"2019","author":"Chang","year":"2019","journal-title":"Oxid. Med. Cell. Longev."},{"key":"10.1016\/j.phrs.2026.108287_bib22","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-018-07447-9","article-title":"Structural basis of RIP2 activation and signaling","volume":"9","author":"Gong","year":"2018","journal-title":"Nat. Commun."},{"key":"10.1016\/j.phrs.2026.108287_bib23","article-title":"RIPK2 is crucial for the microglial inflammatory response to bacterial muramyl dipeptide but not to lipopolysaccharide","volume":"25","author":"Yang","year":"2024","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.phrs.2026.108287_bib24","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2021.650403","article-title":"RIPK2 as a new therapeutic target in inflammatory bowel diseases","volume":"12","author":"Honjo","year":"2021","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.phrs.2026.108287_bib25","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbrc.2017.07.035","article-title":"RIP2 deficiency attenuates cardiac hypertrophy, inflammation and fibrosis in pressure overload induced mice","volume":"493","author":"Zhao","year":"2017","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.phrs.2026.108287_bib26","doi-asserted-by":"crossref","DOI":"10.3389\/fcell.2021.688238","article-title":"Cardiomyocyte-Specific RIP2 Overexpression Exacerbated Pathologic Remodeling and Contributed to Spontaneous Cardiac Hypertrophy","volume":"9","author":"Yang","year":"2021","journal-title":"Front. Cell. Dev. Biol."},{"key":"10.1016\/j.phrs.2026.108287_bib27","article-title":"Z X, G S. Blocking RIPK2 Function Alleviates Myocardial Ischemia\/Reperfusion Injury by Regulating the AKT and NF-\u03baB Pathways","volume":"52","year":"2023","journal-title":"Immunol. Investig."},{"key":"10.1016\/j.phrs.2026.108287_bib28","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejphar.2023.175679","article-title":"RIP2 inhibition alleviates lipopolysaccharide-induced septic cardiomyopathy via regulating TAK1 signaling","volume":"947","author":"Lin","year":"2023","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.phrs.2026.108287_bib29","unstructured":"Gao K. Accropeutics Inc. Announces U.S. FDA Clearance of IND Application for RIPK2 Inhibitor AC-101. biospace; 2024."},{"key":"10.1016\/j.phrs.2026.108287_bib30","article-title":"MG53 Inhibits Necroptosis Through Ubiquitination-Dependent RIPK1 Degradation for Cardiac Protection Following Ischemia\/Reperfusion Injury","volume":"9","author":"Wang","year":"2022","journal-title":"Front. Cardiovasc. Med."},{"key":"10.1016\/j.phrs.2026.108287_bib31","doi-asserted-by":"crossref","DOI":"10.1038\/s41420-024-01957-w","article-title":"RIPK3 signaling and its role in regulated cell death and diseases","volume":"10","author":"Zhou","year":"2024","journal-title":"Cell. Death Discov."},{"key":"10.1016\/j.phrs.2026.108287_bib32","article-title":"Role of Receptor Interacting Protein (RIP) kinases in cancer","volume":"9","author":"Ermine","year":"2022","journal-title":"Genes. & Dis."},{"key":"10.1016\/j.phrs.2026.108287_bib33","doi-asserted-by":"crossref","DOI":"10.26508\/lsa.202201784","article-title":"Structure shows that the BIR2 domain of E3 ligase XIAP binds across the RIPK2 kinase dimer interface","volume":"6","author":"Lethier","year":"2023","journal-title":"Life Sci. Alliance"},{"key":"10.1016\/j.phrs.2026.108287_bib34","doi-asserted-by":"crossref","DOI":"10.15252\/embr.202050400","article-title":"A regulatory region on RIPK2 is required for XIAP binding and NOD signaling activity","volume":"21","author":"Heim","year":"2020","journal-title":"EMBO Rep."},{"key":"10.1016\/j.phrs.2026.108287_bib35","article-title":"A regulatory interface on RIPK2 is required for XIAP binding and NOD signaling activity","author":"Heim","year":"2020","journal-title":"bioRxiv"},{"key":"10.1016\/j.phrs.2026.108287_bib36","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-020-19935-y","article-title":"Ubiquitination of RIPK1 regulates its activation mediated by TNFR1 and TLRs signaling in distinct manners","volume":"11","author":"Li","year":"2020","journal-title":"Nat. Commun."},{"key":"10.1016\/j.phrs.2026.108287_bib37","doi-asserted-by":"crossref","DOI":"10.21037\/tcr.2017.04.01","article-title":"RIPK1-TRAF2 interplay on the TNF\/NF-\u03baB signaling, cell death, and cancer development in the liver","volume":"6","author":"Yamamoto","year":"2017","journal-title":"Transl. Cancer Res."},{"key":"10.1016\/j.phrs.2026.108287_bib38","doi-asserted-by":"crossref","DOI":"10.1155\/2022\/6558060","article-title":"Programmed Cell Death of Endothelial Cells in Myocardial Infarction and Its Potential Therapeutic Strategy","volume":"2022","author":"Wu","year":"2022","journal-title":"Cardiol. Res. Pract."},{"key":"10.1016\/j.phrs.2026.108287_bib39","doi-asserted-by":"crossref","DOI":"10.1084\/jem.20250277","article-title":"RIPK1 S161 phosphorylation promotes further autophosphorylation and cecal necroptosis in TNF-treated mice","volume":"222","author":"Han","year":"2025","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.phrs.2026.108287_bib40","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-020-15466-8","article-title":"Autophosphorylation at serine 166 regulates RIP kinase 1-mediated cell death and inflammation","volume":"11","author":"Laurien","year":"2020","journal-title":"Nat. Commun."},{"key":"10.1016\/j.phrs.2026.108287_bib41","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.1067164","article-title":"Phosphorylation of RIPK1 serine 25 mediates IKK dependent control of extrinsic cell death in T cells","volume":"13","author":"Blanchett","year":"2022","journal-title":"Front. Immunol."},{"key":"10.1016\/j.phrs.2026.108287_bib42","doi-asserted-by":"crossref","DOI":"10.1016\/j.molcel.2017.05.003","article-title":"MK2 Phosphorylates RIPK1 to Prevent TNF-Induced Cell Death","volume":"66","author":"Jaco","year":"2017","journal-title":"Mol. Cell."},{"key":"10.1016\/j.phrs.2026.108287_bib43","doi-asserted-by":"crossref","DOI":"10.1016\/j.cellsig.2024.111374","article-title":"Erbin alleviates sepsis-induced cardiomyopathy by inhibiting RIPK1-dependent necroptosis through activating PKA\/CREB pathway","volume":"123","author":"Zhou","year":"2024","journal-title":"Cell. Signal."},{"key":"10.1016\/j.phrs.2026.108287_bib44","doi-asserted-by":"crossref","DOI":"10.1186\/s11658-024-00649-8","article-title":"m6A-modified circCacna1c regulates necroptosis and ischemic myocardial injury by inhibiting Hnrnpf entry into the nucleus","volume":"29","author":"Jia","year":"2024","journal-title":"Cell. & Mol. Biol. Lett."},{"key":"10.1016\/j.phrs.2026.108287_bib45","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pbio.3002845","article-title":"RIPK1 is required for ZBP1-driven necroptosis in human cells","volume":"23","author":"Amusan","year":"2025","journal-title":"PLOS Biol."},{"key":"10.1016\/j.phrs.2026.108287_bib46","article-title":"A guide to cell death pathways","volume":"25","author":"Yuan","year":"2023","journal-title":"Nat. Rev. Mol. Cell. Biol."},{"key":"10.1016\/j.phrs.2026.108287_bib47","doi-asserted-by":"crossref","DOI":"10.3390\/ijms22157983","article-title":"Inhibition of Cardiac RIP3 Mitigates Early Reperfusion Injury and Calcium-Induced Mitochondrial Swelling without Altering Necroptotic Signalling","volume":"22","author":"Horvath","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.phrs.2026.108287_bib48","doi-asserted-by":"crossref","DOI":"10.3389\/fcvm.2022.927061","article-title":"NLRP3 inflammasome: The rising star in cardiovascular diseases","volume":"9","author":"Zheng","year":"2022","journal-title":"Front. Cardiovasc. Med."},{"key":"10.1016\/j.phrs.2026.108287_bib49","doi-asserted-by":"crossref","DOI":"10.3389\/fphys.2017.00519","article-title":"NLRP3 Inflammasome as a Molecular Marker in Diabetic Cardiomyopathy","volume":"8","author":"Luo","year":"2017","journal-title":"Front. Physiol."},{"key":"10.1016\/j.phrs.2026.108287_bib50","doi-asserted-by":"crossref","DOI":"10.1038\/ncomms7282","article-title":"RIPK3 promotes cell death and NLRP3 inflammasome activation in the absence of MLKL","volume":"6","author":"Lawlor","year":"2015","journal-title":"Nat. Commun."},{"key":"10.1016\/j.phrs.2026.108287_bib51","doi-asserted-by":"crossref","DOI":"10.3390\/cells14191509","article-title":"Myocardial Ischemia\/Reperfusion Injury: Molecular Insights, Forensic Perspectives, and Therapeutic Horizons","volume":"14","author":"Fede","year":"2025","journal-title":"Cells"},{"key":"10.1016\/j.phrs.2026.108287_bib52","doi-asserted-by":"crossref","DOI":"10.1093\/jleuko\/qiad095","article-title":"Dichotomous roles of RIPK3 in regulating the IFN response and NLRP3 inflammasome in human monocytes","volume":"114","author":"Yang","year":"2023","journal-title":"J. Leukoc. Biol."},{"key":"10.1016\/j.phrs.2026.108287_bib53","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2019.07.077","article-title":"RIPK3 Activation Leads to Cytokine Synthesis that Continues after Loss of Cell Membrane Integrity","volume":"28","author":"Orozco","year":"2019","journal-title":"Cell. Rep."},{"key":"10.1016\/j.phrs.2026.108287_bib54","doi-asserted-by":"crossref","DOI":"10.1155\/2021\/6635955","article-title":"RIPK3 Induces Cardiomyocyte Necroptosis via Inhibition of AMPK-Parkin-Mitophagy in Cardiac Remodelling after Myocardial Infarction","volume":"2021","author":"Zhu","year":"2021","journal-title":"Oxid. Med. Cell. Longev."},{"key":"10.1016\/j.phrs.2026.108287_bib55","article-title":"Extracellular RIPK3 Acts as a Damage-Associated Molecular Pattern to Exaggerate Cardiac Ischemia\/Reperfusion Injury","volume":"150","author":"Zhang","year":"2024","journal-title":"Circulation"},{"key":"10.1016\/j.phrs.2026.108287_bib56","doi-asserted-by":"crossref","DOI":"10.1016\/j.cca.2020.06.039","article-title":"Plasma concentration of receptor-interacting protein kinase-3 as a potential biomarker for diagnosis and prognosis in heart failure","volume":"509","author":"Hu","year":"2020","journal-title":"Clin. Chim. Acta"},{"key":"10.1016\/j.phrs.2026.108287_bib57","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2023.114696","article-title":"The pathophysiological role of receptor-interacting protein kinase 3 in cardiovascular disease","volume":"165","author":"Zhang","year":"2023","journal-title":"Biomed. & Pharmacother."},{"key":"10.1016\/j.phrs.2026.108287_bib58","doi-asserted-by":"crossref","DOI":"10.1111\/ajt.12779","article-title":"RIPK3-Mediated Necroptosis Regulates Cardiac Allograft Rejection","volume":"14","author":"Pavlosky","year":"2014","journal-title":"Am. J. Transplant."},{"key":"10.1016\/j.phrs.2026.108287_bib59","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2019.02648","article-title":"The Ubiquitin Code of NODs Signaling Pathways in Health and Disease","volume":"10","author":"Mart\u00ednez-Torres","year":"2019","journal-title":"Front. Immunol."},{"key":"10.1016\/j.phrs.2026.108287_bib60","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCULATIONAHA.119.041213","article-title":"Innate Immune Nod1\/RIP2 Signaling Is Essential for Cardiac Hypertrophy but Requires Mitochondrial Antiviral Signaling Protein for Signal Transductions and Energy Balance","volume":"142","author":"Lin","year":"2020","journal-title":"Circulation"},{"key":"10.1016\/j.phrs.2026.108287_bib61","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0045260","article-title":"NOD1 Activation Induces Cardiac Dysfunction and Modulates Cardiac Fibrosis and Cardiomyocyte Apoptosis","volume":"7","author":"Fern\u00e1ndez-Velasco","year":"2012","journal-title":"PLOS ONE"},{"key":"10.1016\/j.phrs.2026.108287_bib62","doi-asserted-by":"crossref","DOI":"10.1111\/j.1365-2133.2008.08897.x","article-title":"Expression of toll-like receptor 2, NOD2 and dectin-1 and stimulatory effects of their ligands and histamine in normal human keratinocytes","volume":"160","author":"Kobayashi","year":"2009","journal-title":"Br. J. Dermatol."},{"key":"10.1016\/j.phrs.2026.108287_bib63","doi-asserted-by":"crossref","DOI":"10.26508\/lsa.201900346","article-title":"XIAP controls RIPK2 signaling by preventing its deposition in speck-like structures","volume":"2","author":"Ellwanger","year":"2019","journal-title":"Life Sci. Alliance"},{"key":"10.1016\/j.phrs.2026.108287_bib64","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0170232","article-title":"NOD1CARD Might Be Using Multiple Interfaces for RIP2-Mediated CARD-CARD Interaction: Insights from Molecular Dynamics Simulation","volume":"12","author":"Maharana","year":"2017","journal-title":"PLOS ONE"},{"key":"10.1016\/j.phrs.2026.108287_bib65","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2023.1127722","article-title":"Recent advances in the development of RIPK2 modulators for the treatment of inflammatory diseases","volume":"14","author":"Pham","year":"2023","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.phrs.2026.108287_bib66","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0004931","article-title":"Evaluation of Nod-Like Receptor (NLR) Effector Domain Interactions","volume":"4","author":"Wagner","year":"2009","journal-title":"PLoS. ONE"},{"key":"10.1016\/j.phrs.2026.108287_bib67","doi-asserted-by":"crossref","first-page":"17","DOI":"10.15252\/embj.201899372","article-title":"Small molecule inhibitors reveal an indispensable scaffolding role of RIPK2 in NOD2 signaling","volume":"37","author":"Hrdinka","year":"2018","journal-title":"EMBO J."},{"key":"10.1016\/j.phrs.2026.108287_bib68","doi-asserted-by":"crossref","DOI":"10.15252\/embj.201899372","article-title":"Small molecule inhibitors reveal an indispensable scaffolding role of RIPK2 in NOD2 signaling","volume":"37","author":"Hrdinka","year":"2018","journal-title":"EMBO J."},{"key":"10.1016\/j.phrs.2026.108287_bib69","doi-asserted-by":"crossref","DOI":"10.1038\/ncomms7442","article-title":"A RIPK2 inhibitor delays NOD signalling events yet prevents inflammatory cytokine production","volume":"6","author":"Nachbur","year":"2015","journal-title":"Nat. Commun."},{"key":"10.1016\/j.phrs.2026.108287_bib70","article-title":"ERK\/MAPK signalling pathway and tumorigenesis (Review)","volume":"19","author":"Guo","year":"2020","journal-title":"Exp. Ther. Med."},{"key":"10.1016\/j.phrs.2026.108287_bib71","first-page":"404","article-title":"Molecular mechanisms involved in the regulation of cytokine production by muramyl dipeptide - PubMed","author":"M","year":"2007","journal-title":"Biochem. J."},{"key":"10.1016\/j.phrs.2026.108287_bib72","article-title":"RIP2 is a Raf1-activated mitogen-activated protein kinase kinase","volume":"274","author":"TA","year":"1999","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.phrs.2026.108287_bib73","doi-asserted-by":"crossref","DOI":"10.3389\/fnmol.2025.1492807","article-title":"Current advances on RIPK2 and its inhibitors in pathological processes: a comprehensive review","volume":"18","author":"Shen","year":"2025","journal-title":"Front. Mol. Neurosci."},{"key":"10.1016\/j.phrs.2026.108287_bib74","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2014.00070","article-title":"Beyond MyD88 and TRIF Pathways in Toll-Like Receptor Signaling","volume":"5","author":"Piras","year":"2014","journal-title":"Front. Immunol."},{"key":"10.1016\/j.phrs.2026.108287_bib75","doi-asserted-by":"crossref","DOI":"10.4049\/jimmunol.192.Supp.62.3","article-title":"Investigating the mechanism of TLR signaling crosstalk in mouse macrophages (IRM5P.702)","volume":"192","author":"Lin","year":"2014","journal-title":"J. Immunol."},{"key":"10.1016\/j.phrs.2026.108287_bib76","doi-asserted-by":"crossref","DOI":"10.1038\/ni.2563","article-title":"Receptor interacting protein kinase 2-mediated mitophagy regulates inflammasome activation during virus infection","volume":"14","author":"Lupfer","year":"2013","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.phrs.2026.108287_bib77","doi-asserted-by":"crossref","DOI":"10.1038\/s44319-024-00150-5","article-title":"naRNA-LL37 composite DAMPs define sterile NETs as self-propagating drivers of inflammation","volume":"25","author":"Bork","year":"2024","journal-title":"EMBO Rep."},{"key":"10.1016\/j.phrs.2026.108287_bib78","doi-asserted-by":"crossref","DOI":"10.1038\/s41577-024-01027-3","article-title":"DAMP sensing and sterile inflammation: intracellular, intercellular and inter-organ pathways","volume":"24","author":"Huang","year":"2024","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.phrs.2026.108287_bib79","doi-asserted-by":"crossref","DOI":"10.1093\/hmg\/ddac046","article-title":"RIPK4 regulates cell\u2013cell adhesion in epidermal development and homeostasis","volume":"31","author":"Fortugno","year":"2022","journal-title":"Human. Mol. Genet."},{"key":"10.1016\/j.phrs.2026.108287_bib80","doi-asserted-by":"crossref","DOI":"10.7717\/peerj.12932","article-title":"Depletion of RIPK4 parallels higher malignancy potential in cutaneous squamous cell carcinoma","volume":"10","author":"Xu","year":"2022","journal-title":"PeerJ"},{"key":"10.1016\/j.phrs.2026.108287_bib81","article-title":"Insight Into the Function of RIPK4 in Keratinocyte Differentiation and Carcinogenesis","volume":"10","author":"Xu","year":"2020","journal-title":"Front. Oncol."},{"key":"10.1016\/j.phrs.2026.108287_bib82","doi-asserted-by":"crossref","DOI":"10.3390\/antiox15010070","article-title":"Ferroptosis in Myocardial Fibrosis: Mechanisms and Therapeutic Insights","volume":"15","author":"Lin","year":"2026","journal-title":"Antioxidants"},{"key":"10.1016\/j.phrs.2026.108287_bib83","doi-asserted-by":"crossref","DOI":"10.3390\/genes12071047","article-title":"Cardiac Defects and Genetic Syndromes: Old Uncertainties and New Insights","volume":"12","author":"Calcagni","year":"2021","journal-title":"Genes"},{"key":"10.1016\/j.phrs.2026.108287_bib84","doi-asserted-by":"crossref","DOI":"10.3390\/immuno2040039","article-title":"Signaling Pathways in Inflammation and Cardiovascular Diseases: An Update of Therapeutic Strategies","volume":"2","author":"Cucu","year":"2022","journal-title":"Immuno"},{"key":"10.1016\/j.phrs.2026.108287_bib85","article-title":"NF-\u03baB, A Potential Therapeutic Target in Cardiovascular Diseases","volume":"37","author":"Cheng","year":"2022","journal-title":"Cardiovasc. Drugs Ther."},{"key":"10.1016\/j.phrs.2026.108287_bib86","doi-asserted-by":"crossref","DOI":"10.3389\/fphys.2024.1450656","article-title":"Role of ferroptosis in the pathogenesis of heart disease","volume":"15","author":"Fatima","year":"2024","journal-title":"Front. Physiol."},{"key":"10.1016\/j.phrs.2026.108287_bib87","doi-asserted-by":"crossref","DOI":"10.3390\/cells11172726","article-title":"Molecular Mechanisms of Ferroptosis and Relevance to Cardiovascular Disease","volume":"11","author":"Xie","year":"2022","journal-title":"Cells"},{"key":"10.1016\/j.phrs.2026.108287_bib88","doi-asserted-by":"crossref","DOI":"10.1007\/s10565-024-09853-w","article-title":"Ferroptosis mechanisms and regulations in cardiovascular diseases in the past, present, and future","volume":"40","author":"Fang","year":"2024","journal-title":"Cell. Biol. Toxicol."},{"key":"10.1016\/j.phrs.2026.108287_bib89","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-025-61808-9","article-title":"RIPK4-mediated MFN2 degradation drives osteogenesis through mitochondrial fragmentation and restricts myelopoiesis by blocking mitochondrial transfer","volume":"16","author":"Ding","year":"2025","journal-title":"Nat. Commun."},{"key":"10.1016\/j.phrs.2026.108287_bib90","article-title":"RIPK3-Mediated Necroptosis in Diabetic Cardiomyopathy Requires CaMKII Activation","volume":"2021","author":"Chen","year":"2021","journal-title":"Oxid. Med. Cell. Longev."},{"key":"10.1016\/j.phrs.2026.108287_bib91","doi-asserted-by":"crossref","DOI":"10.3389\/fgene.2022.796291","article-title":"Comparative and evolutionary analysis of RIP kinases in immune responses","volume":"13","author":"Lv","year":"2022","journal-title":"Front. Genet."},{"key":"10.1016\/j.phrs.2026.108287_bib92","doi-asserted-by":"crossref","DOI":"10.1016\/j.chembiol.2015.07.017","article-title":"Inflammatory Signaling by NOD-RIPK2 Is Inhibited by Clinically Relevant Type II Kinase Inhibitors","volume":"22","author":"Canning","year":"2015","journal-title":"Chem. & Biol."},{"key":"10.1016\/j.phrs.2026.108287_bib93","article-title":"Insight Into the Function of RIPK4 in Keratinocyte Differentiation and Carcinogenesis","volume":"10","author":"Xu","year":"2020","journal-title":"Front. Oncol."},{"key":"10.1016\/j.phrs.2026.108287_bib94","doi-asserted-by":"crossref","DOI":"10.1021\/acs.jmedchem.9b01317","article-title":"Small-Molecule Inhibitors of Necroptosis: Current Status and Perspectives","volume":"63","author":"Zhuang","year":"2020","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.phrs.2026.108287_bib95","doi-asserted-by":"crossref","DOI":"10.1002\/med.21968","article-title":"Profiling of small-molecule necroptosis inhibitors based on the subpockets of kinase\u2013ligand interactions","volume":"43","author":"Xu","year":"2023","journal-title":"Med. Res. Rev."},{"key":"10.1016\/j.phrs.2026.108287_bib96","doi-asserted-by":"crossref","DOI":"10.1124\/jpet.117.247163","article-title":"Identification and Characterization of Novel Receptor-Interacting Serine\/Threonine-Protein Kinase 2 Inhibitors Using Structural Similarity Analysis","volume":"365","author":"Salla","year":"2018","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.phrs.2026.108287_bib97","doi-asserted-by":"crossref","DOI":"10.5582\/bst.2016.01077","article-title":"Serum levels of RIPK3 and troponin I as potential biomarkers for predicting impaired left ventricular function in patients with myocardial infarction with ST segment elevation and normal troponin I levels prior percutaneous coronary intervention","volume":"10","author":"Kashlov","year":"2016","journal-title":"Biosci. Trends"},{"key":"10.1016\/j.phrs.2026.108287_bib98","article-title":"Enhanced nuclear localization of phosphorylated MLKL predicts adverse events in patients with dilated cardiomyopathy - PubMed","volume":"9","author":"Y","year":"2022","journal-title":"ESC Heart Fail."},{"key":"10.1016\/j.phrs.2026.108287_bib99","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2023.115380","article-title":"Regulatory mechanism of CaMKII \u03b4 mediated by RIPK3 on myocardial fibrosis and reversal effects of RIPK3 inhibitor GSK'872","volume":"166","author":"Zhang","year":"2023","journal-title":"Biomed. & Pharmacother."},{"key":"10.1016\/j.phrs.2026.108287_bib100","doi-asserted-by":"crossref","DOI":"10.3390\/biomedicines12040802","article-title":"Myocardial Ischemia\u2013Reperfusion Injury: Unraveling Pathophysiology, Clinical Manifestations, and Emerging Prevention Strategies","volume":"12","author":"Sagris","year":"2024","journal-title":"Biomedicines"},{"key":"10.1016\/j.phrs.2026.108287_bib101","article-title":"Regulated necrosis: disease relevance and therapeutic opportunities","volume":"15","author":"Conrad","year":"2016","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.phrs.2026.108287_bib102","doi-asserted-by":"crossref","DOI":"10.3390\/antiox14020190","article-title":"Eleutheroside B Ameliorates Cardiomyocytes Necroptosis in High-Altitude-Induced Myocardial Injury via Nrf2\/HO-1 Signaling Pathway","volume":"14","author":"Duan","year":"2025","journal-title":"Antioxidants"},{"key":"10.1016\/j.phrs.2026.108287_bib103","doi-asserted-by":"crossref","DOI":"10.1093\/abbs\/gmy108","article-title":"The role of RIP3 in cardiomyocyte necrosis induced by mitochondrial damage of myocardial ischemia\u2013reperfusion","volume":"50","author":"Hou","year":"2018","journal-title":"Acta Biochim. Et. Biophys. Sin."},{"key":"10.1016\/j.phrs.2026.108287_bib104","doi-asserted-by":"crossref","DOI":"10.1038\/nm.4017","article-title":"CaMKII is a RIP3 substrate mediating ischemia- and oxidative stress\u2013induced myocardial necroptosis","volume":"22","author":"Zhang","year":"2016","journal-title":"Nat. Med."},{"key":"10.1016\/j.phrs.2026.108287_bib105","doi-asserted-by":"crossref","DOI":"10.1016\/j.redox.2018.02.019","article-title":"Ripk3 promotes ER stress-induced necroptosis in cardiac IR injury: A mechanism involving calcium overload\/XO\/ROS\/mPTP pathway","volume":"16","author":"Zhu","year":"2018","journal-title":"Redox Biol."},{"key":"10.1016\/j.phrs.2026.108287_bib106","doi-asserted-by":"crossref","DOI":"10.3389\/fcvm.2022.847362","article-title":"Ca2+\/Calmodulin-Dependent Protein Kinase II Regulation by RIPK3 Alleviates Necroptosis in Transverse Arch Constriction-Induced Heart Failure","volume":"9","author":"Cao","year":"2022","journal-title":"Front. Cardiovasc. Med."},{"key":"10.1016\/j.phrs.2026.108287_bib107","doi-asserted-by":"crossref","DOI":"10.1111\/jcmm.14408","article-title":"A common variant of RIP3 promoter region is associated with poor prognosis in heart failure patients by influencing SOX17 binding","volume":"23","author":"Hu","year":"2019","journal-title":"J. Cell. Mol. Med."},{"key":"10.1016\/j.phrs.2026.108287_bib108","doi-asserted-by":"crossref","first-page":"07","DOI":"10.1126\/sciadv.1600224","article-title":"Targeting macrophage necroptosis for therapeutic and diagnostic interventions in atherosclerosis","volume":"2","author":"Karunakaran","year":"2016","journal-title":"Sci. Adv."},{"key":"10.1016\/j.phrs.2026.108287_bib109","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCRESAHA.116.304899","article-title":"Receptor-interacting protein kinase 3 contributes to abdominal aortic aneurysms via smooth muscle cell necrosis and inflammation","volume":"116","author":"Wang","year":"2015","journal-title":"Circ. Res."},{"key":"10.1016\/j.phrs.2026.108287_bib110","doi-asserted-by":"crossref","DOI":"10.1186\/s12933-022-01602-9","article-title":"MLKL-mediated necroptosis is a target for cardiac protection in mouse models of type-1 diabetes","volume":"21","author":"Cao","year":"2022","journal-title":"Cardiovasc. Diabetol."},{"key":"10.1016\/j.phrs.2026.108287_bib111","doi-asserted-by":"crossref","DOI":"10.1016\/j.yexcr.2022.113417","article-title":"Silencing RIPK1\/mTORC1 signalling attenuated the inflammation and oxidative stress in diabetic cardiomyopathy","volume":"422","author":"Liu","year":"2023","journal-title":"Exp. Cell. Res."},{"key":"10.1016\/j.phrs.2026.108287_bib112","doi-asserted-by":"crossref","DOI":"10.1097\/FJC.0000000000001293","article-title":"The regulatory mechanism and effect of receptor-interacting protein kinase 3 on phenylephrine-induced cardiomyocyte hypertrophy","volume":"80","author":"Wang","year":"2022","journal-title":"J. Cardiovasc. Pharmacol."},{"key":"10.1016\/j.phrs.2026.108287_bib113","article-title":"Preliminary study of necroptosis in cardiac hypertrophy induced by pressure overload","author":"Zhao","year":"2016","journal-title":"J. Biomed. Eng."},{"key":"10.1016\/j.phrs.2026.108287_bib114","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbadis.2025.167898","article-title":"Empagliflozin attenuates DOX-induced cardiotoxicity by inhibiting RIPK1-mediated endoplasmic reticulum stress and autophagy","volume":"1871","author":"Wang","year":"2025","journal-title":"Biochim. Et. Biophys. Acta Mol. basis Dis."},{"key":"10.1016\/j.phrs.2026.108287_bib115","doi-asserted-by":"crossref","DOI":"10.1016\/j.jphs.2024.06.005","article-title":"Contribution of MLKL to the development of doxorubicin-induced cardiomyopathy and its amelioration by rapamycin","volume":"156","author":"Shimizu","year":"2024","journal-title":"J. Pharmacol. Sci."},{"key":"10.1016\/j.phrs.2026.108287_bib116","article-title":"RIPK3 inhibitor GSK872 targets angiotensin II induced cardiomyocyte hypertrophy by regulating Ca2+\/ calmodulin dependent protein kinase II","volume":"21","author":"Zhang","year":"2026","journal-title":"PLOS ONE"},{"key":"10.1016\/j.phrs.2026.108287_bib117","doi-asserted-by":"crossref","DOI":"10.1007\/s10495-025-02146-5","article-title":"Research progress on programmed cell death of cardiomyocytes in pressure-overload hypertrophic cardiomyopathy","volume":"30","author":"Xiao","year":"2025","journal-title":"Apoptosis"},{"key":"10.1016\/j.phrs.2026.108287_bib118","first-page":"54","article-title":"The resurrection of RIP kinase 1 as an early cell death checkpoint regulator\u2014a potential target for therapy in the necroptosis era","author":"Ju","year":"2022","journal-title":"Exp. & Mol. Med."},{"key":"10.1016\/j.phrs.2026.108287_bib119","doi-asserted-by":"crossref","DOI":"10.1038\/s12276-018-0152-8","article-title":"HS-1371, a novel kinase inhibitor of RIP3-mediated necroptosis","volume":"50","author":"Park","year":"2018","journal-title":"Exp. Mol. Med."},{"key":"10.1016\/j.phrs.2026.108287_bib120","article-title":"Case Report: Hyperbilirubinemia in Gilbert Syndrome Attenuates Covid-19-Induced Metabolic Disturbances","volume":"8","author":"Al-kuraishy","year":"2021","journal-title":"Front. Cardiovasc. Med."},{"key":"10.1016\/j.phrs.2026.108287_bib121","article-title":"Effects of diabetic pharmacotherapy on prolactin hormone in patients with type 2 diabetes mellitus: Bane or Boon","volume":"10","author":"Rasheed","year":"2019","journal-title":"J. Adv. Pharm. Technol. Res."},{"issue":"17","key":"10.1016\/j.phrs.2026.108287_bib122","first-page":"22","article-title":"Inflammatory Signaling by NOD-RIPK2 is inhibited by clinically relevant type II kinase inhibitors","volume":"09","author":"Canning","year":"2015","journal-title":"Chem. Biol."},{"key":"10.1016\/j.phrs.2026.108287_bib123","doi-asserted-by":"crossref","DOI":"10.3389\/fphys.2020.00694","article-title":"Lifestyle, oxidative stress, and antioxidants: back and forth in the pathophysiology of chronic diseases","volume":"11","author":"Sharifi-Rad","year":"2020","journal-title":"Front. Physiol."},{"key":"10.1016\/j.phrs.2026.108287_bib124","article-title":"Necroptosis in bacterial infections","volume":"15","author":"Yu","year":"2024","journal-title":"Front. Immunol."},{"key":"10.1016\/j.phrs.2026.108287_bib125","doi-asserted-by":"crossref","DOI":"10.1111\/cts.13857","article-title":"A phase I randomized study to evaluate safety, pharmacokinetics, and pharmacodynamics of SIR2446M, a selective RIPK1 inhibitor, in healthy participants","volume":"17","author":"Sun","year":"2024","journal-title":"Clin. Transl. Sci."},{"key":"10.1016\/j.phrs.2026.108287_bib126","doi-asserted-by":"crossref","DOI":"10.1042\/BST20220535","article-title":"The role of RHIM in necroptosis","volume":"50","author":"Riebeling","year":"2022","journal-title":"Biochem. Soc. Trans."},{"key":"10.1016\/j.phrs.2026.108287_bib127","doi-asserted-by":"crossref","DOI":"10.1038\/s41419-019-1396-5","article-title":"Redundant and receptor-specific activities of TRADD, RIPK1 and FADD in death receptor signaling","volume":"10","author":"F\u00fcllsack","year":"2019","journal-title":"Cell. Death Dis."},{"key":"10.1016\/j.phrs.2026.108287_bib128","doi-asserted-by":"crossref","DOI":"10.1039\/C5MB00212E","article-title":"Structural and functional insights into CARDs of zebrafish (Danio rerio) NOD1 and NOD2, and their interaction with adaptor protein RIP2","volume":"11","author":"Maharana","year":"2015","journal-title":"Mol. Biosyst."}],"container-title":["Pharmacological Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1043661826002021?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1043661826002021?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,7,26]],"date-time":"2026-07-26T13:55:34Z","timestamp":1785074134000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1043661826002021"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8]]},"references-count":128,"alternative-id":["S1043661826002021"],"URL":"https:\/\/doi.org\/10.1016\/j.phrs.2026.108287","relation":{},"ISSN":["1043-6618"],"issn-type":[{"value":"1043-6618","type":"print"}],"subject":[],"published":{"date-parts":[[2026,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Receptor-interacting protein kinases (RIPK1\u2013RIPK4) in cardiac pathophysiology: Mechanistic signaling, disease contexts, and emerging pharmacological targets","name":"articletitle","label":"Article Title"},{"value":"Pharmacological Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.phrs.2026.108287","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"108287"}}